What is the clinical significance of an estimated glomerular filtration rate of 72 mL/min/1.73 m² in a 42‑year‑old female and what follow‑up is recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clinical Significance of eGFR 72 mL/min/1.73 m² in a 42-Year-Old Female

An eGFR of 72 mL/min/1.73 m² in a 42-year-old woman does NOT constitute chronic kidney disease unless evidence of kidney damage is present. 1

Understanding the GFR Category

  • This patient falls into KDIGO category G2 (eGFR 60–89 mL/min/1.73 m²), which represents "mildly decreased GFR" 2, 1
  • G2 alone is insufficient for CKD diagnosis—you must document kidney damage persisting >3 months 2, 1
  • Normal GFR in young adults is approximately 125 mL/min/1.73 m², so 72 represents roughly 58% of expected normal function 2
  • However, healthy adults commonly have eGFR values >63.5 mL/min/1.73 m² without disease 3

Required Next Steps to Determine CKD Status

You must actively search for evidence of kidney damage through:

  1. Measure urine albumin-to-creatinine ratio (UACR) 1

    • A1 (<30 mg/g) = normal to mildly increased 1
    • A2 (30–300 mg/g) = moderately increased, confirms CKD 1
    • A3 (>300 mg/g) = severely increased, confirms CKD 1
  2. Repeat serum creatinine and eGFR within 3 months to verify chronicity 1

  3. Review for other damage markers 1:

    • Kidney imaging abnormalities (cysts, scarring, asymmetry)
    • Urine sediment abnormalities (hematuria, cellular casts)
    • Blood/urine composition abnormalities (electrolyte disorders from tubular dysfunction)
    • Pathological findings if biopsy performed
  4. Consider cystatin C measurement if eGFR approaches 60 or clinical uncertainty exists, as approximately two-thirds of borderline cases are reclassified when cystatin C is added 1

Clinical Interpretation

  • If UACR is normal (<30 mg/g) and no other damage markers exist: This is NOT CKD; the eGFR of 72 likely represents normal variation for this individual 1, 3
  • If UACR ≥30 mg/g or other damage is present: CKD is confirmed and should be classified as G2A2 (or A3) with identified cause 2, 1

Risk Stratification

  • An eGFR of 72 without albuminuria carries low risk for adverse kidney and cardiovascular outcomes 2
  • Population-based data show eGFR values below the 25th percentile for age/sex are associated with increased mortality and kidney failure risk 4
  • At age 42, median population eGFR is substantially higher than 72, placing this patient potentially below the 25th percentile and warranting albuminuria assessment 4

Follow-Up Recommendations

If no kidney damage is found:

  • No CKD diagnosis warranted 1
  • Repeat eGFR annually if risk factors present (diabetes, hypertension, family history) 5
  • No nephrology referral needed 1

If CKD is confirmed (damage present):

  • Annual monitoring of eGFR and UACR 1
  • Increase monitoring to quarterly if treatment targets not met 1
  • Implement kidney-protective interventions: RAS inhibition if albuminuria present, blood pressure optimization (<120 mmHg systolic if tolerated), SGLT2 inhibitor if diabetic, lifestyle modification 5
  • Nephrology referral is NOT indicated at eGFR 72 unless progressive decline, increasing albuminuria, or uncertain etiology develops 1

Common Pitfalls to Avoid

  • Do not diagnose CKD based on a single eGFR value in the G2 range without confirming damage 1
  • Do not assume age-related decline—at 42 years, this eGFR warrants investigation 2, 4
  • Do not skip albuminuria testing—it is mandatory to complete the diagnostic evaluation 1
  • Do not refer to nephrology prematurely—referral thresholds are eGFR <30, progressive decline, or diagnostic uncertainty 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.